|
Forming Alliances to forge ahead
SIRO Clinpharm and RegRx Consulting, LLC
Alliance provides solutions related to US drug regulatory solutions for pharmaceutical companies
RegRx Consulting, LLC is a select group of highly skilled regulatory affairs professionals with over 50 years of combined experience with the US FDA (CDER/CBER) and other regulatory authorities. They provide consulting services and solutions to US and foreign pharmaceutical companies who need assistance with development and commercial drug regulatory affairs.
They handle Overall regulatory development strategy, maintaining INDs and NDAs, due diligence from the array of services. They have handled multiple Regulatory Applications pertaining to NDA, IND, CTDs, CTA and ANDA.
SIRO Clinpharm and Virginia Contract Research Organization
Pact enables SIRO’s clients access to booming Taiwan clinical research market
VCRO is one of the most experienced CROs with the longest history in Taiwan’s contract research sector. VCRO is dedicated to offering
full range ICH-GCP compliant clinical research services including EDC, IVRS and analytical laboratory services for pharmaceutical and biotech
companies. They have an extensive network in the Asia-Pacific regions of Japan, China, Singapore and Hong Kong.
This alliance is a collaborative partnership and will help us deliver value arising out of clinical capabilities and wider geographies to our global
set of clients.
SIRO Clinpharm and DreamCIS
Pact will broaden SIRO’s reach in Asian Clinical trials sector
DreamCIS is a South Korea based CRO with close to a decade’s experience in offering clinical
research services to pharmaceutical companies, bio venture companies, medical device manufacturers, and
functional food producers. Their services range includes Clinical trial management, Pharmacovigilance,
Post Marketing Surveillance (PMS), Data management, Biostatistics and Quality Assurance services.
This partnership is ideally created to provide a sustainable value for our existing as well as potential
customers in the rapidly growing Korean clinical trials market.
|